We are actively seeking strategic and institutional investors for our Platform Technology AI MRI company, Bot Image, Inc
12 Reasons To Invest In Bot Image
1. Bot Image’s first proprietary technology ProstatID TM has been developed in coordination with the NIH and UCLA. ProstatID was FDA cleared for marketing in July 2022.
2. An attractive business model with low overhead and high returns. Our projected profit model only requires capturing .06% of the entire United States market.
3. Industry leadership with an experienced management team and board of directors that have an excellent track record of bringing novel diagnostic imaging technologies to market cost-effectively with high financial returns.
4. Robust industry-specific sales channels developed over two decades gives us a strong competitive position.
5. Disciplined financial policies that focus on maintaining a strong and stable capital structure and cash flow growth.
6. A clear road map for expansion, focused on executing an attractive portfolio of AI projects to adapt to emerging markets.
7. Vertically-integrated business covering the entire downstream segment of the magnetic resonance industry with transparent group structure with defined business segments and product lines.
8. Committed to optimizing our investments with full transparency to generate value and sustained growth.
9. Maintains a high pace of innovation and owns a self-financed portfolio of new products with reported and controlled costs.
10. Growth from multiple dimensions including the development of new technologies, leveraging current platforms to develop new products and applications, and geographical expansion capabilities.
11. Technologies and products that reduce the cost of medical care, improve diagnostic accuracy, and save lives.
12. Attractive market with immense projected growth profile, the AI market is forecasted to hit $15.7 billion and healthcare to hit $14.8 trillion by 2030.
If you'd like to learn more about the investment opportunity with Bot Image, please fill out the contact form and we will be in touch.